# FDA recall Z-3214-2026

> **Boston Scientific Corporation** · Class I · device recall initiated 2026-08-24.

## Product

Imager II Angiographic Catheters    M001314001  IMAGER II/5/ST/65/038 BX5;    M001314011  IMAGER II/5/ST/100/038 BX5;    M001314021  IMAGER II/5/ST/65/035 BX 5;    M001314031  IMAGER II/5/ST/100/035 BX 5;    M001314041  IMAGER II/5/BARNH/100/038 BX5;    M001314051  IMAGER II/5/BERN/100/038 BX5;    M001314061  IMAGER II/5/BERN/100/035 BX 5;    M001314081  IMAGER II/5/BERN/40/038 BX5;    M001314101  IMAGER II/5/BERN/65/038 BX5;    M001314141  IMAGER II/5/H1/100/038 BX5;    M001314151  IMAGER II/5/H1/100/035 BX 5;    M001314301  IMAGER II/5/SIM1/65/038 BX5;    M001314321  IMAGER II/5/SIM1/100/038 BX5;    M001314341  IMAGER II/5/SIM2/100/038 BX5;    M001314351  IMAGER II/5/SIM2/100/035 BX 5;    M001314361  IMAGER II/5/SIM3/100/038 BX5;    M001314521  IMAGER II/5/CHGB/65/038 BX5;    M001314581  IMAGER II/5/CONTRA 2/65/038 BX5;    M001314621  IMAGER II/5/C1/65/038 BX5;    M001314661  00AGER II/5/C2/65/038 BX5;    M001314671  IMAGER II/5/C2/65/035 BX 5;    M001314761  IMAGER II/5/MIK/65/038 BX5;    M001314771  IMAGER II/5/MIK/65/035 BX 5;    M001314821  IMAGER II/5/SHK1.0/65/038 BX5;    M001314861  IMAGER II/5/RC2/65/038 BX5;    M001314881  IMAGER II/5/RDC/65/038 BX5

## Reason for recall

Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.

## Distribution

Worldwide - US Nationwide and territories of Puerto Rico and the countries of Albania, Algeria, Argentina, Australia, Austria, Barbados, Belgium, Brazil, Brunei Dar-es-S, Bulgaria, Cambodia, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, France, Georgia, Germany, Greece, Guatemala, Hong Kong, Hungary, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Oman, Pakistan, Panama, Poland, Portugal, Puerto Rico, Qatar, Rep N Macedonia, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Trinidad, Tobago, Tunisia, T¿rkiye, UAE, Ukraine, United Kingdom, USA, W. Bank Gaza Strip, Yemen.

## Key facts

- **Recall number:** Z-3214-2026
- **Recalling firm:** Boston Scientific Corporation
- **Classification:** Class I
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2026-08-24
- **Report date:** 2026-09-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Maple Grove, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-3214-2026

## Citation

> MORVS. FDA recall Z-3214-2026. Retrieved 2026-11-22 from https://api.morvs.ai/recall/Z-3214-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
